Phone: (888) 7-NOVATE
Founded in 1998, Novation
is the leading health care supply contracting company for the more than 65,000 members of VHA Inc. and UHC, two national health care alliances, and Provista, LLC. Novation provides alliance members sourcing services, as well as information and data services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC and Provista members used Novation contracts to purchase more than $40 billion in 2011.
inVentiv Clinical Solutions
For clients seeking to accelerate business performance, inVentiv Health offers Clinical, Commercial and Consulting services to pharmaceutical, biotechnology, medical device and diagnostic clients all over the world. In a time of dynamic change in the industry, clients turn to our company to develop new compounds, create winning business strategies and successfully commercialize products or services.http://infuse.inventivhealth.com/
BioProcess International holds fiduciary responsibility to be the publishing leader of cutting edge technologies, improved processes and breakthrough sciences that serve two main purposes:
• assist the biopharmaceutical industry in improving the quality, speed and number of treatments available to patients;
• provide leading suppliers with dedicated and focused editorial environments to effectively introduce your products, services, brands and expertise to targeted decision makers.
For more information visit www.bioprocessintl.com.
BiosimilarNews.com is a weblog to share the knowledge about biosimilars. We wanted to build up a detailed source for professionals and also for the public. Our only aim is to share our knowledge and also keep in touch with the professionals who are working in this specific area.
We keep you up to date.
Clinical Leader is an
online community that helps streamline clinical research by connecting trial
sponsors and cutting edge service providers. In browsing the site, users can
view and download a variety of industry-related content from our supplier
directory, product showcase, and resource centers. This content is designed to
help sponsors select potential partners and products to aid in clinical
Current Agreements is a premium subscription database providing comprehensive business information and intelligence with access to thousands of contract documents, giving coverage of all deals and alliances across the life sciences sector since 2000. View more information at: www.currentagreements.comhttp://www.currentagreements.com/
Current Partnering report titles cover all aspects of partnering best practice and deal terms, providing users with the information and insight required to optimise their partnering activities.
Life Science Leader
Leader strives to be an essential business tool for Life Science executives.
The editorial is designed to provide readers with content pertaining to the
life cycle of Life Science products and services. Our goal is to provide
information that helps high-level industry personnel improve profits and
overcome hurdles within the industry.
Generics and Biosimilars Initiative (GaBI) was founded in 2008. GaBI aims to foster the worldwide efficient use of high quality and safe medicines at an affordable price, thus advancing and supporting the idea of accessible, affordable and sustainable healthcare.
GaBI Online (www.gabionline.net) is a one-stop portal for global news on recent developments in the field of generics and biosimilars, a repository of worldwide guidelines and an archive of related scientific information.
GaBI Journal – official Journal of the Generics and Biosimilars Initiative (www.gabi-journal.net) is an independent, peer reviewed academic Journal – it encompasses all aspects of generic and biosimilar medicines development and use, from fundamental research to clinical application and policies.
GaBI’s mission – building trust in cost effective treatments
Ltang@gabionline.net | www.gabionline.net | www.gabi-journal.net
Generics bulletin is the global generic industry’s essential source of news and views on product launches, company deals, regulatory changes and patent pricing and reimbursement issues. Two formats: a weekly electronic newsflash and a twice-monthly paper publication provide both immediacy and depth from a generics industry perspective. For further information please visit www.generics-bulletin.com or contact Val Davis at email@example.com or call +44 (0)1564 777550.
is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Innovaro Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Innovaro Pharmalicensing, and its sister service Innovaro Medical Device Licensing
are actively utilized by over 200,000 industry professionals each month. Innovaro Pharmalicensing is part of Innovaro Inc, listed on AMEX (INV).
"New Pharma is a pharmaceutical magazine like no other, with exclusive content specializing in Generics, Otc, Biosimilar and Animal Health. Key topics include strategy, marketing, technology, business culture, law and emerging markets. New Pharma Magazine is not a science journal and is focused on engaging readers on a corporate level, in terms of strategy and direction of the industry over all.
"New Pharma is an exciting new publication that reflects the need for strategic thinking in a changing industry" - Ed Borkowski, former CFO Mylan
New Pharma Magazine is available in print and digital. You can subscribe FOR FREE on the newly launched website and gain access to premium content, industry events, news and partners"
Orange Book Blog
Orange Book Blog (www.orangebookblog.com
) covers issues at the intersection of patent law and pharmaceutical regulation – for example, Hatch-Waxman litigation, FDA citizen petitions, and antitrust. Orange Book Blog is authored by Aaron F. Barkoff, Ph.D., a partner at the intellectual property law firm McDonnell Boehnen Hulbert & Berghoff LLP, in Chicago.
Pharmaceutical Outsourcing is a bi-monthly journal dedicated to
pharmaceutical and biopharmaceutical contract services. With regular sections
on clinical trials, clinical research, contract research, contract packaging,
formulation/development services, contract analytical testing, APIs, and
contract manufacturing, we bring the most complete coverage of trends and
issues in the industry.
Pharmaceutical Outsourcing is a business unit of CompareNetworks, Inc.
The CompareNetworks websites empower scientists and healthcare professionals
with marketplaces to enhance their productivity. An extensive directory of more
than 2 Million products combined with thousands of technical articles and videos,
makes the CompareNetworks websites the most comprehensive and up-to-date b2b
marketplaces on the Web. In addition to Pharmaceutical Outsourcing,
CompareNetworks websites include DrugDevCompare, American Pharmaceutical Review, Biocompare,
American Laboratory and Labcompare,
PharmaVOICE magazine, reaching more than 29,000 BPA-qualified
life-sciences executives, is the forum that allows business leaders to
engage in a candid dialogue on the challenges and trends impacting the
industry. PharmaVOICE provides readers with insightful and
thought-provoking commentary in a multiple-perspective format through
forums, topics, and articles covering a range of issues from molecule
through market. PharmaVOICE subscribers are also kept abreast of the
latest trends and information through additional media resources,
including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White
Papers, E-Surveys and e-Alerts. Additionally, PharmaVOICEMarketplace.com
provides a comprehensive directory of products, services, and solutions
for the life-sciences industry.
To Raise Your VOICE, contact firstname.lastname@example.org
Special offer: a FREE subscription to PharmaVOICE magazine. Read the magazine that gives VOICE to a changing industry. Start
Your Subscription Today!
Player or investor, lawyer or contractor, if you need to know pharma, you need to know ScripWorld Pharmaceutical News. Most people in the industry do. We've been the leading provider of global pharmaceutical news for over thirty years.
Thomson Reuters can provide the knowledge, tools and expertise to help support your drug discovery and development activities, optimize your IP portfolio, identify licensing and partnering opportunities, deliver successful regulatory submissions, keep you in touch with the rapidly-changing pharmaceutical and chemical markets, and make informed, early decisions.